+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Osteoarthritis Pain Drug Market by Product Type, Route Of Administration, Distribution Channel, End User, Patient Age Group, Disease Severity - Global Forecast 2025-2030- Product Image
Osteoarthritis Pain Drug Market by Product Type, Route Of Administration, Distribution Channel, End User, Patient Age Group, Disease Severity - Global Forecast 2025-2030- Product Image
Sale

Osteoarthritis Pain Drug Market by Product Type, Route Of Administration, Distribution Channel, End User, Patient Age Group, Disease Severity - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4995456
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The osteoarthritis pain drug market is transforming as clinical innovation, digital health integration, and evolving regulatory demands converge. Senior decision-makers must respond to dynamic market drivers, anticipate shifts in therapy paradigms, and leverage advanced technologies to stay ahead in this complex segment.

Market Snapshot: Osteoarthritis Pain Drug Market Expansion

The osteoarthritis pain drug market grew from USD 8.54 billion in 2024 to USD 9.12 billion in 2025. It is expected to continue growing at a CAGR of 6.50%, reaching USD 12.47 billion by 2030. Steady population aging and increasing prevalence of osteoarthritis are fueling sectoral growth, prompting healthcare providers to seek advanced therapies and broadening industry opportunities. Rising investment in R&D and targeted treatment development continue to solidify this trajectory, while competition intensifies as new players, delivery technologies, and clinical data emerge.

Scope & Segmentation: Targeted Insights Across Demographics, Products, and Regions

This report delivers granular coverage of market developments, supported by expert interviews and multi-source validation. Market segmentation addresses therapeutic approaches, patient populations, administration methods, distribution, and global regions. The main segmentation dimensions include:

  • Product Types: Covers corticosteroids, cyclooxygenase 2 inhibitors, nonsteroidal anti-inflammatory drugs, symptomatic slow-acting drugs, and viscosupplements. Each group targets specific pain and inflammation pathways and presents differentiated risk and efficacy profiles.
  • Routes of Administration: Explores injectable formats (intra-articular and intramuscular), oral options (capsules, liquids, tablets), and topical preparations (creams, gels, patches), ensuring coverage of localized and systemic pain management needs.
  • Distribution Channels: Analyzes hospital pharmacies, online pharmacies, and retail models, reflecting the evolving purchase and delivery preferences among end users.
  • End Users: Examines clinics, home healthcare, and hospitals, each with distinct procurement and usage patterns shaped by their unique patient base and care philosophies.
  • Patient Age Groups: Details adolescents under 18, adults 18 to 64, and the elderly 65+, highlighting different efficacy, safety, and adherence requirements.
  • Disease Severity: Segments therapies for mild, moderate, and severe osteoarthritis, guiding development priorities and regulatory considerations.
  • Geographic Regions: Americas (with a focus on the US, Canada, Brazil, and Mexico), Europe, Middle East & Africa (including the UK, Germany, UAE, and South Africa), and Asia-Pacific (covering China, Japan, India, and Australia).
  • Leading Companies: Includes Pfizer Inc., Novartis AG, Bayer AG, Johnson & Johnson, Sanofi S.A., GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, and Perrigo Company plc.

Key Takeaways for Decision-Makers

  • Therapeutic pipelines prioritize disease-modifying and patient-centric agents to address long-term needs and improve quality of life for diverse populations.
  • Digital health solutions and remote monitoring are becoming standard, supporting greater personalization and enhanced outcome tracking in real time.
  • Customized segment strategies are essential, as preferences for oral, injectable, or topical therapies differ across patient groups and healthcare settings.
  • Regional policy variance—such as heightened value-based care in the Americas or infrastructure modernization in the Middle East—demands adaptive approaches to access, pricing, and reimbursement.
  • Strategic alliances, particularly with technology or digital health companies, are accelerating the development and commercialization cycle by enabling integrated drug-device offerings.
  • Manufacturers increasingly focus on simplifying supply chains and reducing complexity, especially for products addressing severe disease or requiring advanced manufacturing.

Tariff Impact: Navigating Pharmaceutical Import Duties in the US

New US import duties on key ingredients and finished products are altering sourcing and production decisions. These tariffs are creating downstream cost pressures and prompting companies to review global supplier relationships, shift toward near-shoring, and adopt data-driven supply chain analytics. Tariff-related adjustments are also affecting procurement processes, with hospital and large-group tenders now reflecting new cost structures. Manufacturers must remain agile to manage these evolving economic risks and safeguard access to osteoarthritis pain therapies.

Methodology & Data Sources

The report draws upon in-depth interviews with industry leaders, systematic literature reviews, regulatory filings, and proprietary market databases. Data triangulation, scenario modeling, and expert panel validation ensure reliable, actionable market intelligence and insight into evolving trends in the osteoarthritis pain drug market.

Why This Report Matters

  • Empowers leaders to align R&D investment and market access strategies with shifting clinical, regulatory, and payer priorities.
  • Enables proactive risk management by revealing how policy shifts and regional trends may impact sourcing, pricing, and end-user access across the osteoarthritis pain drug market.
  • Supports data-driven decisions through robust segmentation, highlighting opportunities for differentiated value creation and sustained growth.

Conclusion

The osteoarthritis pain drug market presents substantial opportunity for those equipped with nuanced, data-driven strategies. This report delivers focused insights to support strategic planning, mitigate risks, and drive long-term value across the evolving pain management landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of subcutaneous monoclonal anti-NGF therapies showing improved pain relief durability in moderate to severe osteoarthritis
5.2. Emergence of sustained release intra-articular hydrogel formulations extending therapeutic effects beyond twelve weeks for knee osteoarthritis
5.3. Growing off-label use of low-dose oral cannabinoids supported by patient preference for alternative chronic osteoarthritis pain management
5.4. Escalating investment in digital health platforms integrating wearable joint motion sensors with personalized pain management apps
5.5. Increasing prevalence of biosimilar development targeting biosafety and cost reduction in anti-TNF therapies for osteoarthritis inflammation
5.6. Implementation of real-world evidence studies evaluating comparative effectiveness of non-opioid analgesics in diverse osteoarthritis populations
5.7. Expansion of combination therapies pairing NSAIDs with adjunctive nerve growth factor blockers to minimize gastrointestinal and cardiovascular risks
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Osteoarthritis Pain Drug Market, by Product Type
8.1. Introduction
8.2. Corticosteroids
8.3. Cyclooxygenase 2 Inhibitors
8.4. Nonsteroidal Anti-Inflammatory Drugs
8.5. Symptomatic Slow Acting Drugs
8.6. Viscosupplements
9. Osteoarthritis Pain Drug Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.2.1. Intra Articular
9.2.2. Intramuscular
9.3. Oral
9.3.1. Capsules
9.3.2. Liquid
9.3.3. Tablets
9.4. Topical
9.4.1. Cream
9.4.2. Gel
9.4.3. Patch
10. Osteoarthritis Pain Drug Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Osteoarthritis Pain Drug Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Healthcare
11.4. Hospitals
12. Osteoarthritis Pain Drug Market, by Patient Age Group
12.1. Introduction
12.2. Adolescents Under 18
12.3. Adults 18 64
12.4. Elderly 65+
13. Osteoarthritis Pain Drug Market, by Disease Severity
13.1. Introduction
13.2. Mild
13.3. Moderate
13.4. Severe
14. Americas Osteoarthritis Pain Drug Market
14.1. Introduction
14.2. Brazil
14.3. Canada
14.4. Mexico
14.5. Argentina
14.6. United States
15. Europe, Middle East & Africa Osteoarthritis Pain Drug Market
15.1. Introduction
15.2. United Arab Emirates
15.3. Turkey
15.4. Saudi Arabia
15.5. Poland
15.6. Norway
15.7. France
15.8. Israel
15.9. Denmark
15.10. Sweden
15.11. Qatar
15.12. South Africa
15.13. Netherlands
15.14. Russia
15.15. Switzerland
15.16. Italy
15.17. Finland
15.18. United Kingdom
15.19. Nigeria
15.20. Germany
15.21. Egypt
15.22. Spain
16. Asia-Pacific Osteoarthritis Pain Drug Market
16.1. Introduction
16.2. Indonesia
16.3. Vietnam
16.4. Australia
16.5. India
16.6. Thailand
16.7. Philippines
16.8. Malaysia
16.9. South Korea
16.10. Japan
16.11. Taiwan
16.12. Singapore
16.13. China
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Pfizer Inc.
17.3.2. Novartis AG
17.3.3. Bayer AG
17.3.4. Johnson & Johnson
17.3.5. Sanofi S.A.
17.3.6. GlaxoSmithKline plc
17.3.7. Viatris Inc.
17.3.8. Teva Pharmaceutical Industries Ltd.
17.3.9. Sandoz International GmbH
17.3.10. Perrigo Company plc
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. OSTEOARTHRITIS PAIN DRUG MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. OSTEOARTHRITIS PAIN DRUG MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. OSTEOARTHRITIS PAIN DRUG MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. OSTEOARTHRITIS PAIN DRUG MARKET: RESEARCHAI
FIGURE 28. OSTEOARTHRITIS PAIN DRUG MARKET: RESEARCHSTATISTICS
FIGURE 29. OSTEOARTHRITIS PAIN DRUG MARKET: RESEARCHCONTACTS
FIGURE 30. OSTEOARTHRITIS PAIN DRUG MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. OSTEOARTHRITIS PAIN DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CYCLOOXYGENASE 2 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CYCLOOXYGENASE 2 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY SYMPTOMATIC SLOW ACTING DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY SYMPTOMATIC SLOW ACTING DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY VISCOSUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY VISCOSUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INTRA ARTICULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INTRA ARTICULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ADOLESCENTS UNDER 18, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ADOLESCENTS UNDER 18, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ADULTS 18 64, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ADULTS 18 64, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ELDERLY 65+, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ELDERLY 65+, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MILD, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MILD, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MODERATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MODERATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY SEVERE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY SEVERE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 121. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 126. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 127. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 128. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 129. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 130. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 131. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 136. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 137. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 138. CANADA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 139. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 142. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 143. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 146. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 147. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 148. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 149. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 154. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 155. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 156. MEXICO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 233. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 234. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 235. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 238. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 239. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 240. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 241. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 242. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 243. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 248. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 249. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 250. TURKEY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 254. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 256. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 269. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 272. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 273. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 274. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 275. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 276. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 277. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 278. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 279. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 284. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 285. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 286. POLAND OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 287. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 292. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 293. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 294. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 295. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 296. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 297. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 302. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 303. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 304. NORWAY OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 305. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 308. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 309. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 310. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 311. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 312. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 313. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 314. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 315. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 320. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 321. FRANCE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018

Samples

Loading
LOADING...

Companies Mentioned

  • Pfizer Inc.
  • Novartis AG
  • Bayer AG
  • Johnson & Johnson
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Perrigo Company plc

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.47 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Hip Osteoarthritis Pain Drug Market by Mechanism Of Action (Corticosteroids, Hyaluronic Acid, Nonsteroidal Anti-Inflammatory Drugs), Route Of Administration (Injectable, Oral, Topical), End User, Patient Age Group - Global Forecast 2025-2030 - Product Image

Hip Osteoarthritis Pain Drug Market by Mechanism Of Action (Corticosteroids, Hyaluronic Acid, Nonsteroidal Anti-Inflammatory Drugs), Route Of Administration (Injectable, Oral, Topical), End User, Patient Age Group - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Osteoarthritic Pain Drug Pipeline Analysis Report 2025 - Product Image

Osteoarthritic Pain Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Neuropathic Pain Drug Market by Product Type (Anticonvulsants, Antidepressants, Opioids), Route Of Administration (Intravenous, Oral, Topical), Indication, Distribution Channel - Global Forecast 2025-2030 - Product Image

Neuropathic Pain Drug Market by Product Type (Anticonvulsants, Antidepressants, Opioids), Route Of Administration (Intravenous, Oral, Topical), Indication, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Acute Pain Drug Pipeline Analysis Report 2025 - Product Image

Acute Pain Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Neuropathic Pain Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Neuropathic Pain Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Osteoarthritis Pain Drug Market

Analgesics are drugs used to relieve pain. Osteoarthritis pain is a common type of pain that can be treated with analgesics. Osteoarthritis is a degenerative joint disease that causes pain, stiffness, and swelling in the joints. Analgesics used to treat osteoarthritis pain include nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and opioids. NSAIDs are the most commonly used analgesics for osteoarthritis pain, as they reduce inflammation and pain. Acetaminophen is also used to reduce pain, but it does not reduce inflammation. Opioids are used for severe pain, but they can be addictive and have side effects. Companies in the Osteoarthritis Pain Drug market include Pfizer, Merck, Johnson & Johnson, Novartis, and GlaxoSmithKline. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.